Sufficient trial size to inform clinical practice

被引:25
|
作者
Manski, Charles F. [1 ,2 ]
Tetenov, Aleksey [3 ,4 ]
机构
[1] Northwestern Univ, Dept Econ, Evanston, IL 60208 USA
[2] Northwestern Univ, Inst Policy Res, Evanston, IL 60208 USA
[3] Univ Bristol, Dept Econ, Bristol BS8 1TU, Avon, England
[4] Coll Carlo Alberto, I-10024 Moncalieri, TO, Italy
关键词
clinical trials; sample size; medical decision making; near optimality; REGRET TREATMENT CHOICE; TREATMENT RULES; ETHICS; STATISTICS; PLACEBO; DESIGN;
D O I
10.1073/pnas.1612174113
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Medical research has evolved conventions for choosing sample size in randomized clinical trials that rest on the theory of hypothesis testing. Bayesian statisticians have argued that trials should be designed to maximize subjective expected utility in settings of clinical interest. This perspective is compelling given a credible prior distribution on treatment response, but there is rarely consensus on what the subjective prior beliefs should be. We use Wald's frequentist statistical decision theory to study design of trials under ambiguity. We show that e-optimal rules exist when trials have large enough sample size. An e-optimal rule has expected welfare within e of the welfare of the best treatment in every state of nature. Equivalently, it has maximum regret no larger than e. We consider trials that draw predetermined numbers of subjects at random within groups stratified by covariates and treatments. We report exact results for the special case of two treatments and binary outcomes. We give simple sufficient conditions on sample sizes that ensure existence of e-optimal treatment rules when there are multiple treatments and outcomes are bounded. These conditions are obtained by application of Hoeffding large deviations inequalities to evaluate the performance of empirical success rules.
引用
收藏
页码:10518 / 10523
页数:6
相关论文
共 50 条
  • [31] THE CASE FOR ELDER ABUSE SEVERITY MEASURES TO INFORM CLINICAL PRACTICE
    Burnes, D.
    Pillemer, K.
    Lachs, M.
    GERONTOLOGIST, 2015, 55 : 11 - 11
  • [32] How can observational trials inform and improve clinical practice?
    Home, Philip D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 88 : S1 - S2
  • [33] Clinical trial size and efficacy
    Feldman, SR
    Fleischer, AB
    DERMATOLOGIC SURGERY, 1999, 25 (08) : 670 - 671
  • [34] Clinical practice guidelines on trial
    Hayward, RSA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1997, 156 (12) : 1725 - 1727
  • [35] Preclinical rare cancer research to inform clinical trial design
    Holly E. Barker
    Clare L. Scott
    Nature Reviews Cancer, 2019, 19 : 481 - 482
  • [36] Using real world data to inform clinical trial design
    Houghton, Richard
    Golding, Sophie
    Rizzo, Shemra
    Sanglier, Thibaut
    Schroder, Carsten
    Shah, Jigna
    Spain, C. Victor
    Zhang, Qing
    Furby, Hannah V.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 582 - 583
  • [37] THE USE OF HISTORICAL CLINICAL TRIAL DATA TO INFORM SURVIVAL EXTRAPOLATION
    Pham, H. A.
    Smalbrugge, D.
    Kroi, F.
    Heeg, B.
    Ouwens, M.
    VALUE IN HEALTH, 2022, 25 (01) : S10 - S10
  • [38] Reporting clinical trial results to inform providers, payers, and consumers
    Hayward, RA
    Kent, DM
    Vijan, S
    Hofer, TP
    HEALTH AFFAIRS, 2005, 24 (06) : 1571 - 1581
  • [39] Patient involvement to inform the design of a clinical trial in postbariatric hypoglycaemia
    Hepprich, Matthias
    Donath, Marc Y.
    Hemkens, Lars G.
    BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
  • [40] USE OF QUALITY OF LIFE DATA TO INFORM CLINICAL TRIAL OUTCOMES
    Price, P.
    WOUND REPAIR AND REGENERATION, 2015, 23 (04) : A23 - A23